Fatal agranulocytosis: The use of olanzapine in a patient with schizophrenia and myelodysplasia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 1, 2007, Pages 297-300

  Stip, Emmanuel ^a,b   Langlois, Robert ^a   Thuot, Claude ^c   Mancini Marïe, Adham ^a  

^a CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Agranulocytosis; Myelodyslastic Syndrome; Neutropenia; Olanzapine; Schizophrenia; Zyprexa

Indexed keywords

AMITRIPTYLINE; BIPERIDEN; CHLORAL HYDRATE; CITALOPRAM; CLOZAPINE; CREATININE; DIAZEPAM; DIPHENHYDRAMINE; DONEPEZIL; FLURAZEPAM; HALOPERIDOL; HEMOGLOBIN; HYDROCHLOROTHIAZIDE; LEVODOPA; LEVOMEPROMAZINE; LITHIUM; LORAZEPAM; METIXENE; NIFEDIPINE; OLANZAPINE; PERGOLIDE; PHENOTHIAZINE DERIVATIVE; PIMOZIDE; QUETIAPINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RISPERIDONE; STEROID; THIAZIDE DIURETIC AGENT; VALPROIC ACID;

ADULT; AGRANULOCYTOSIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CAUSE OF DEATH; CHROMOSOME 11; CHROMOSOME DELETION; CREATININE BLOOD LEVEL; CYTOGENETICS; DIFFERENTIAL DIAGNOSIS; DIURETIC THERAPY; DRUG DOSE INCREASE; DRUG METABOLISM; DRUG WITHDRAWAL; GRANULOCYTOPENIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY FAILURE; LEUKOCYTE COUNT; LEUKOPENIA; MACROCYTIC ANEMIA; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; PANCYTOPENIA; PATIENT MONITORING; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; THROMBOCYTE COUNT; THROMBOCYTOPENIA; URETER MALFORMATION;

ADULT; AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BLOOD CELL COUNT; BONE MARROW CELLS; FATAL OUTCOME; HUMANS; MALE; NEURAL TUBE DEFECTS; NEUTROPENIA; SCHIZOPHRENIA, PARANOID;

EID: 33845874689     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.08.005     Document Type: Article

References (35)

1. Abdullah N., Voronovitch L., Taylor S., and Lippmann S. Olanzapine and haloperidol: potential for neutropenia?. Psychosomatics 44 1 (2003) 83-84
2. Benedetti F., Cavallaro R., and Smeraldi E. Olanzapine-induced neutropenia after clozapine-induced neutropenia. Lancet 354 9178 (1999) 567
3. Buchman N., Strous R.D., Ulman A.M., Lerner M., and Kotler M. Olanzapine-induced leukopenia with human leukocyte antigen profiling. Int Clin Psychopharmacol 16 1 (2001) 55-57
4. Chatterton R. Experiences with clozapine and olanzapine. Aust N Z J Psychiatry 32 3 (1998) 463
5. Chrein M.B., and Rubin I.L. Agranulocytosis secondary to hydrochlorothiazide therapy. Report of a case. JAMA 181 (1962) 54-55
6. Cordes J., Streit M., Loeffler S., von Wilmsdorff M., Agelink M., and Klimke A. Reversible neutropenia during treatment with olanzapine: three case reports. World J Biol Psychiatry 5 4 (2004) 230-234
7. Delieu, JM, Horobin, RW, Duguid, JK. Formation of immature neutrophil leucocytes in schizophrenic patients treated with various antipsychotic drugs: comparisons and predictions. J Psychopharmacol in press (Epub ahead of print).
8. Dernovsek M.Z., and Tavcar R. Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone. Int Clin Psychopharmacol 15 4 (2000) 237-238
9. Dettling M., Cascorbi I., Hellweg R., Deicke U., Weise L., and Muller-Oerlinghausen B. Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?. Pharmacopsychiatry 32 3 (1999) 110-112
10. Diaz P., and Hogan T.P. Granulocytopenia with clozapine and quetiapine. Am J Psychiatry 158 4 (2001) 651
11. Duggal H.S., Gates C., and Pathak P.C. Olanzapine-induced neutropenia: mechanism and treatment. J Clin Psychopharmacol 24 2 (2004) 234
12. Etain B., Roubaud L., Le Heuzey M.F., and Mouren Simeoni M.C. A case of leukopenia in treatment with risperidone in an adolescent. Encephale 26 5 (2000) 81-84
13. Finkel B., Lerner A.G., Oyffe I., and Sigal M. Risperidone-associated agranulocytosis. Am J Psychiatry 155 6 (1998) 855-856
14. Gajwani P., and Tesar G.E. Olanzapine-induced neutropenia. Psychosomatics 41 2 (2000) 150-151
15. Godleski L.S., and Sernyak M.J. Agranulocytosis after addition of risperidone to clozapine treatment. Am J Psychiatry 153 5 (1996) 735-736
16. Hong X., and Wang X. Agranulocytosis and neutropenia with typical and atypical neuroleptics. Am J Psychiatry 158 10 (2001) 1736-1737
17. Kodesh A., Finkel B., Lerner A.G., Kretzmer G., and Sigal M. Dose-dependent olanzapine-associated leukopenia: three case reports. Int Clin Psychopharmacol 16 2 (2001) 117-119
18. Konakanchi R., Grace J.J., Szarowicz R., and Pato M.T. Olanzapine prolongation of granulocytopenia after clozapine discontinuation. J Clin Psychopharmacol 20 6 (2000) 703-704
19. Krupp P., and Barnes P. Leponex-associated granulocytopenia: a review of the situation. Psychopharmacology (Berl) 99 (1989) S118-S121 [Suppl]
20. Meissner W., Schmidt T., Kupsch A., Trottenberg T., and Lempert T. Reversible leucopenia related to olanzapine. Mov Disord 14 5 (1999) 872-873
21. Montgomery J. Ziprasidone-related agranulocytosis following olanzapine-induced neutropenia. Gen Hosp Psychiatry 28 1 (2006) 83-85
22. Naumann R., Felber W., Heilemann H., and Reuster T. Olanzapine-induced agranulocytosis. Lancet 354 9178 (1999) 566-567
23. Oyewumi L.K., and Al-Semaan Y. Olanzapine: safe during clozapine-induced agranulocytosis. J Clin Psychopharmacol 20 2 (2000) 279-281
24. Ruhe H.G., Becker H.E., Jessurun P., Marees C.H., Heeringa M., and Vermeulen H.D. Agranulocytosis and granulocytopenia associated with quetiapine. Acta Psychiatr Scand 104 4 (2001) 311-313 [discussion 313-4]
25. Sayin A., and Cosar B. Prolongation of clozapine-induced leukopenia with olanzapine treatment. Prog Neuropsychopharmacol Biol Psychiatry 30 5 (2006) 958-959
26. Schotland M.G., and Grumbach M.M. Neutropenia in an infant secondary to hydrochlorothiazide therapy: with a review of hematologic reactions to "thiazide" drugs. Pediatrics 31 (1963) 754-757
27. Schuld A., Kraus T., Hinze-Selch D., Haack M., and Pollmacher T. Granulocyte colony-stimulating factor plasma levels during clozapine- and olanzapine-induced granulocytopenia. Acta Psychiatr Scand 102 2 (2000) 153-155
28. Steinwachs A., Grohmann R., Pedrosa F., Ruther E., and Schwerdtner I. Two cases of olanzapine-induced reversible neutropenia. Pharmacopsychiatry 32 4 (1999) 154-156
29. Stergiou V., Bozikas V.P., Garyfallos G., Nikolaidis N., Lavrentiadis G., and Fokas K. Olanzapine-induced leucopenia and neutropenia. Prog Neuropsychopharmacol Biol Psychiatry 29 6 (2005) 992-994
30. Stubner S., Grohmann R., Engel R., Bandelow B., Ludwig W.D., Wagner G., et al. Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry 37 Suppl 1 (2004) S70-S78
31. Swartz J.R., Ananth J., Smith M.W., Burgoyne K.S., Gadasally R., and Arai Y. Olanzapine treatment after clozapine-induced granulocytopenia in 3 patients. J Clin Psychiatry 60 2 (1999) 119-121
32. Teter C.J., Early J.J., and Frachtling R.J. Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution. J Clin Psychiatry 61 11 (2000) 872-873
33. Thangadurai P., Jyothi K.S., Gopalakrishnan R., Kuruvilla A., and Jacob K.S. Reversible neutropenia with olanzapine following clozapine-induced neutropenia. Am J Psychiatry 163 7 (2006) 1298
34. Tolosa-Vilella C., Ruiz-Ripoll A., Mari-Alfonso B., and Naval-Sendra E. Olanzapine-induced agranulocytosis: a case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 26 2 (2002) 411-414
35. Wray C.M., and Sztuke-Fournier A. Olanzapine: hematological reactions. CMAJ 159 1 (1998) 81-82